These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
212 related articles for article (PubMed ID: 15274387)
1. Correlation of serum VEGF levels with clinical stage, therapy efficacy, tumor metastasis and patient survival in ovarian cancer. Li L; Wang L; Zhang W; Tang B; Zhang J; Song H; Yao D; Tang Y; Chen X; Yang Z; Wang G; Li X; Zhao J; Ding H; Reed E; Li QQ Anticancer Res; 2004; 24(3b):1973-9. PubMed ID: 15274387 [TBL] [Abstract][Full Text] [Related]
2. [Study on serum vascular endothelial growth factor level in ovarian malignant tumors]. Li L; Wang LM; Zhang W; Zhang JQ; Song HL; Yao DS; Tang Y; Chen XQ; Yang ZH Zhonghua Fu Chan Ke Za Zhi; 2003 Feb; 38(2):72-6. PubMed ID: 12783691 [TBL] [Abstract][Full Text] [Related]
3. Prognostic relevance of serum vascular endothelial growth factor in ovarian cancer. Oehler MK; Caffier H Anticancer Res; 2000; 20(6D):5109-12. PubMed ID: 11326678 [TBL] [Abstract][Full Text] [Related]
5. Soluble vascular endothelial growth factor levels in patients with primary colorectal carcinoma. The Danish RANX05 Colorectal Cancer Study Group. Werther K; Christensen IJ; Brünner N; Nielsen HJ Eur J Surg Oncol; 2000 Nov; 26(7):657-62. PubMed ID: 11078612 [TBL] [Abstract][Full Text] [Related]
6. The potential clinical relevance of serum vascular endothelial growth factor (VEGF) and VEGF-C in recurrent papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Lang BH; Leung P; Luk JM Surgery; 2008 Dec; 144(6):934-40; discussion 940-1. PubMed ID: 19041000 [TBL] [Abstract][Full Text] [Related]
7. Serum vascular endothelial growth factor C correlates with lymph node metastases and high-risk tumor profiles in papillary thyroid carcinoma. Yu XM; Lo CY; Lam AK; Leung P; Luk JM Ann Surg; 2008 Mar; 247(3):483-9. PubMed ID: 18376194 [TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease. Kraft A; Weindel K; Ochs A; Marth C; Zmija J; Schumacher P; Unger C; Marmé D; Gastl G Cancer; 1999 Jan; 85(1):178-87. PubMed ID: 9921991 [TBL] [Abstract][Full Text] [Related]
9. [Clinical significance of quantitative analysis of serum VEGF, CD44s, and MMP-3 protein in nasopharyngeal carcinoma]. Li YH; Shao JY; Li S; Zou BY; Huang HQ; Guan ZZ Ai Zheng; 2004 Sep; 23(9):1060-4. PubMed ID: 15363202 [TBL] [Abstract][Full Text] [Related]
10. Serum vascular endothelial growth factor-C and lymphoangiogenesis are associated with the lymph node metastasis and prognosis of patients with colorectal cancer. Wang TB; Chen ZG; Wei XQ; Wei B; Dong WG ANZ J Surg; 2011 Oct; 81(10):694-9. PubMed ID: 22295309 [TBL] [Abstract][Full Text] [Related]
11. [Relationship between serum VEGF level and VEGF, COX-2 and MVD expression in breast cancer tissues]. Li EX; Wu YY; Shi F; Wu Y; Guo JJ; Dong DF Zhonghua Zhong Liu Za Zhi; 2007 Jul; 29(7):522-5. PubMed ID: 18069633 [TBL] [Abstract][Full Text] [Related]
12. The clinical relevance of serum vascular endothelial growth factor (VEGF) in correlation to circulating tumor cells and other serum biomarkers in patients with metastatic breast cancer. Banys-Paluchowski M; Witzel I; Riethdorf S; Pantel K; Rack B; Janni W; Fasching PA; Aktas B; Kasimir-Bauer S; Hartkopf A; Solomayer EF; Fehm T; Müller V Breast Cancer Res Treat; 2018 Nov; 172(1):93-104. PubMed ID: 30003393 [TBL] [Abstract][Full Text] [Related]
13. Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival. Chen CA; Cheng WF; Lee CN; Chen TM; Kung CC; Hsieh FJ; Hsieh CY Gynecol Oncol; 1999 Aug; 74(2):235-40. PubMed ID: 10419737 [TBL] [Abstract][Full Text] [Related]
14. [Serum level and expression of vascular epithelial growth factor in ovarian epithelial carcinoma]. Sun LX; Wu Y; Han HQ; Wang QH Ai Zheng; 2003 Jan; 22(1):58-61. PubMed ID: 12561438 [TBL] [Abstract][Full Text] [Related]
15. Prospective validation of the prognostic value of elevated serum vascular endothelial growth factor in patients with nasopharyngeal carcinoma: more distant metastases and shorter overall survival after treatment. Lv X; Xiang YQ; Cao SM; Qian CN; Li NW; Guo L; Mai HQ; Chen QY; Huang PY; Luo D; Cao KJ; Hong MH; Guo X Head Neck; 2011 Jun; 33(6):780-5. PubMed ID: 20967862 [TBL] [Abstract][Full Text] [Related]
16. Serum preoperative vascular endothelial growth factor (VEGF) in epithelial ovarian cancer: relationship with prognostic variables and clinical outcome. Gadducci A; Ferdeghini M; Fanucchi A; Annicchiarico C; Ciampi B; Prontera C; Genazzani AR Anticancer Res; 1999; 19(2B):1401-5. PubMed ID: 10365113 [TBL] [Abstract][Full Text] [Related]
17. [The relationship between lymphatic metastasis and serum vascular endothelial growth factor C and cyclooxygenase 2 expression in breast cancer]. Li EX; Shi F; Wu YY; Wu Y; Guo JJ; Dong DF Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(2):88-91. PubMed ID: 18353210 [TBL] [Abstract][Full Text] [Related]
18. Serum sErbB1 and epidermal growth factor levels as tumor biomarkers in women with stage III or IV epithelial ovarian cancer. Baron AT; Lafky JM; Boardman CH; Balasubramaniam S; Suman VJ; Podratz KC; Maihle NJ Cancer Epidemiol Biomarkers Prev; 1999 Feb; 8(2):129-37. PubMed ID: 10067810 [TBL] [Abstract][Full Text] [Related]
19. Serum vascular endothelial growth factor-C combined with multi-detector CT in the preoperative diagnosis of lymph node metastasis of gastric cancer. Wang TB; Wang J; Wei XQ; Wei B; Dong WG Asia Pac J Clin Oncol; 2012 Jun; 8(2):180-6. PubMed ID: 22524577 [TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer. Yabushita H; Shimazu M; Noguchi M; Kishida T; Narumiya H; Sawaguchi K; Noguchi M Oncol Rep; 2003; 10(1):89-95. PubMed ID: 12469150 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]